The Swiss Times - Swiss News in English

Alain Delon gets counselor for medical decisions

The family dispute surrounding 88-year-old French film star Alain Delon is entering the next round. The actor has been assigned a guardian for medical decisions by the judiciary, as the news agency AFP learned on Monday.

Alain Delon's three children recently argued about where and how their father should be treated.

Delon had suffered several strokes and, according to his children, can only make himself understood with difficulty. A doctor had already certified that he was no longer able to manage his own affairs. The public prosecutor's office had requested a further medical report.

Among other things, the dispute between the three children revolves around the question of whether the actor should spend the rest of his life in his residence in France or move to Switzerland, where his daughter Anouchka lives - and where inheritance tax is likely to be lower. Delon also has Swiss citizenship.

According to his eldest son Anthony Delon, Alain Delon stipulated in his will that his daughter Anouchka should inherit half of his estate and his two sons a quarter each. In public, the actor often preferred his daughter Anouchka to his sons.

According to the French media, she not only has a leading position in the company that manages her father's licenses and advertising contracts, but also a villa with its own swimming pool on Delon's property in Douchy, south of Paris. She was the only one to accompany Delon in Cannes in 2019 when he received a Palm d'Honneur for his lifetime achievement.


Most Read

Barry Callebaut to Cut 2,500 Jobs

26 February 2024
Barry Callebaut
Barry Callebaut, the world's largest chocolate manufacturer, announces significant job cuts as part of its "BC Next Level" savings plan.

Swiss Electricity Prices to Dip Slightly in 2025, Uvek Reports

29 February 2024
Swiss electricity prices
Swiss Electricity Prices expected to decrease in 2025 as DETEC reduces the capital cost rate for electricity grid investments.

Kuehne+Nagel Stabilise in 2023: Plans For Expansion

1 March 2024
Kuehne+Nagel Future
Kuehne+Nagel normalise growth after corona, despite a downturn, the firm aims for strategic growth and stability.

Swiss Competition Commission: Investigate UBS Now

1 March 2024
Swiss Competition Commission
Swiss Competition Commission seeks an in-depth investigation into UBS after the CS merger, highlighting possible market dominance issues.

Stay in Touch!


Flixbus Total Sales Over Two Billion Euros For the First Time
29 February 2024
Zambon Group
Zambon Group: Exclusive Licensing Deal for IPX203 in Europe
29 February 2024